1 / 51

Klinisk og genetisk forskning på døvblindhed-3 Tverrfaglighed- CHARGE syndrom

Klinisk og genetisk forskning på døvblindhed-3 Tverrfaglighed- CHARGE syndrom. Eikholt 23.8-24.8.2011 Lisbeth Tranebjærg tranebjaerg@sund.ku.dk. Døvhetssyndromer:CHARGE, dynamik rundt diagnose, nye metoder.Tverrfaglige tiltak. Lisbeth Tranebjærg tranebjaerg@sund.ku.dk.

ardith
Download Presentation

Klinisk og genetisk forskning på døvblindhed-3 Tverrfaglighed- CHARGE syndrom

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Klinisk og genetisk forskning på døvblindhed-3Tverrfaglighed- CHARGE syndrom Eikholt 23.8-24.8.2011 Lisbeth Tranebjærg tranebjaerg@sund.ku.dk

  2. Døvhetssyndromer:CHARGE, dynamik rundt diagnose, nye metoder.Tverrfaglige tiltak Lisbeth Tranebjærg tranebjaerg@sund.ku.dk

  3. Implications of a diagnosisDiagnosis-prognosis-treatment-counselling • Distinguish between genetic/non-genetic cause (CRS vs CHARGE, chromosomal abnormality) • Be tuned for early assessment of associated medical problems (WFS1 related disease/Usher syndrome/Alström) • Be prepared for progressive/stable condition, and guide choice of treatment (CI or not) and method of communication (CHARGE/Usher) • The parents always will ask: WHY OUR CHILD??

  4. Rubella • Congenit rubella syndrom har likhetstrekk med CHARGE syndrom

  5. Congenital Rubella syndrome (CRS) • Created the awareness towards congenital deafblindness in general • Has almost disappeared as etiology • Miscarriage, hearing impairment, cataract, heart malformations, mental delay • Late -manifestations: diabetes mellitus, hypertension, neurological and psycho-social problems, endocrine abnormalities, early menopause, osteoporosis, progressive rubella panencephalitis(learning disability, ataxia, cerebral palsy, psychosis)

  6. CRS-Dammeyer, 2010 Dammeyer J Int J Pediatr Otorhinol 2010 ;74:1067-1070

  7. Late manifestations of congenital rubella syndrome (CRS) ?Are they real? • 123 congenital deafblind adult individuals (evaluated in 2003) • N= 35 with CRS – average age 41 years • No evidence for more frequent occurrence of the postulated late-manifeatations cp with a group of 82 non-CRS cong deafblind individuals (etiology other or unknown) (Dammeyer J et al, 2010)

  8. Rubella? CHARGE? • Kvinne LC født 141258: • Syg Tvillinge søster GC141258 døde 1993 • LC født af 18 år gl kvinne, serologisk bekræftet rubella tidligt i svangerskabet. Afslag på ab. Prov. (!!!) • Jente tvillinger født med alvorlige misdannelser • CHD7-sekventering og and MLPA analyse af CDH7 var normale. • Konklusion: Congenital Rubella Syndrome.

  9. Tværfaglig udredning af syns-og høretab

  10. Multidisciplinarity in hereditary hearing impairment-examining the patient Family history Clinical photos CT scan, Eye exam, Renal US Array CGH Genetic counselling Hearing impairment GJB2 and other genes Geography and ethnicity Audiological profile Bioinformatics

  11. C-H-A-R-G-E Association (1979) • C: Coloboma • H: Heart malformation • A: Atresia Choanae • R: Retarded growth and development • G: Genital-urinvejsabnormiteter • E: Ear anomaly and/or hearing impairment (Pagon et al, 1981) This list no longer is recommended for diagnosis

  12. Epidemiologi Autosomal dominant syndrom- de fleste tilfælde er sporadiske Prævalens: Skøn: 1: 10.000- 1: 15.000 Canada: 1: ~ 8.500 levendefødte (UK: 250 pts) Ca 8 nye børn pr år i DK (?) Næsthyppigste årsag hos børn med døvblindhed 20% ud af 67 børn (Dammeyer J, Int J Audiol, 2010;49: 76-82)

  13. CHARGE:fra klinisk beskrivelse til så meget mere • 1979/81: Hall/Pagon- Diagnostiske kriterier • 2004: en spec pt: med chrom 8abn: CHD7 • 2005-2006: > 200 pts mutationsanalyseret • De sjældnere dukker op: familiære tilfælde, Kallman’s syndrom (oftest++), påvisning af de-novomutation, sandsynliggøring af køns celle mosaik • % af pts med påvist CHD7 mutation først meget høj (65-70%). • Raten falder når flere klinisk variable pts us. • Flere gener (type 1- type 2 etc)? Hvor mange? • Næsthyppigste ætiologi hos danske døvblinde børn (20/67) (Dammeyer J, Int J Audiol, 2010;49: 76-82)

  14. Clinical criteria for CHARGE syndrome

  15. Clinical criteria for CHARGE syndrome

  16. Overview of features occurring in CHARGE syndrome (frequencies are shown in table 2). Bergman J E H et al. J Med Genet 2011;48:334-342 ©2011 by BMJ Publishing Group Ltd

  17. Patient with typical CHARGE syndrome and a 22q11 deletion. Bergman J E H et al. J Med Genet 2011;48:334-342 ©2011 by BMJ Publishing Group Ltd

  18. Kliniske karakteristika Meta-analysis from 25 reports:254 pts with CDH7 mutations, and 125 were negative → Zentner GE et al. Molecular and phenotypic aspects of CHD7 mutation in CHARGE syndrome. Am J Med Genet 2010; 152A: 674-686

  19. Klinik- hollandske erfaringer

  20. Klinik-hollandske erfaringer-cont’d

  21. Typer af mutationer Mekanismesandsynligvishaploinsufficiens da punktmutationer og total deletion af CHD7 giver sammekliniskebillede. ZentnerGE et al. Molecular and phenotypic aspects of CHD7 mutation in CHARGE syndrome. Am J Med Genet 2010; 152A: 674-686

  22. Guideline for CHD7 analysis in patients suspected of CHARGE syndrome. Bergman J E H et al. J Med Genet 2011;48:334-342 ©2011 by BMJ Publishing Group Ltd

  23. Atypiske CHARGE pts

  24. CHARGE-familial case-Fam A Diagnostic criteria: Major:1/3 1/3 2/3 Minor:2/5 5/5 3/5 Delahaye A et al. Clin Genet 2007; 72: 112-121

  25. CHARGE-Familiær Fam A: • III:2: læbe-ganespalte, øsophagus atresi+ fistel, complex hjertefeil, og ribbensanomalier, lærevansker, ingen anosmi, kortvokst • III:3: retina colobom, ingen hjertefeil, gik 21 mdr gl, • II:2: asymptomatisk vestibulær abnormiteter, retina colobom- diagnosticeret efter børnenes diagnose, balanceproblemer som barn, normal mentalt. (Mosaik i kønsceller for mutationen?) • CHD7 mutation: c.2501C>T; p.S834F • (Delahaye A et al, 2007)

  26. Familial Kallmann syndrom with CHD7 mutation • 19-y-old woman. Affected sister Anacusis dxt, anosmia, coloboma n. Opt. dxt, ptosis sin, very delayed growth and puberty, lack of growth hormone. H:164 cm, Bilat vesico-uret reflux, Pregnant x2→ Spont ab. • Father: anacusis sin, dupl ureter sin, died of AMI 40-y-old, coarctatio aortae. H:179 cm- not available for genetic test. • Sister:anacusis sin, anosmia, no coloboma,bilat vesico-uret reflux, delayed puberty,no deficiency of growth hormone. H:165 cm • MRI: missing the olfactory sulcus Mother healthy; no CHD7 mutation CHD7 mutation:exon 31: c.6221T>C; p.L2074P Neuropsychology: Deficient continous attention, memory,in particular visual, and reduced cognitive flexibility. Functions badly in work life,extremely easily distracted and works slowly Levy CM & Knudtzon J.Clin Genet 1993; 43:51-53 Kallmann syndrome: lack of spontaneous puberty+ anosmia- many causes

  27. CHARGE syndrome- old pt • 56-year old cong.deaf-blind female- protected living conditions- • An older brother died perinatally with similar malformations • Clinically: HA from age 17 years: conductive/sensorineural HI,right ear deaf • Eyes: left blind, glasses from age 42 years, incipient cataract,scars in retina, no colobomas • Never mentruated,hyperthyroidism,adipose • Broadbased gait, poor balance • Heart malformation • Unilateral facial paresis • Emotionally fragile • Peculiar behaviour • CHD7-sequencing: c.7252C>T: p.R2418X/N • CT scan of temporal bones: Mondini dysplasia, complete agenesis of semicircular canals,small orbital coloboma

  28. Atypical CHARGE- late diagnosis • MH 090801, 1. child- born to Turkish consanguineous parents • In 2002: severe HI diagnosed- sign language • Agenesis of acoustic nerve unilaterally, bilat agenesis of semicircular canals • CI operation had to be refused • No coloboma, or choanal atresia • Major problems with coordination of vision due to paresis of the abducens nerve • Hardly any feeding problems, good olfactory sense • Short stature (6,5 år gl: 103 cm) • Aud afd, neuropaediatrician, dept for growth and reproduction,eye dept: none raised the CHARGE suspicion • CHARGE diagnosis obtained by deafblind coordinator and geneticist in 2007

  29. CHARGE adfærd fænotype(udkast-T.Hartshorne) • Lav normal cognitiv funktion • Meget målrettet, persisterende, og humoristisk sans • Socialt interesseret, men umoden • Repetitiv adfærd, øges under stress • Søger meget intenst sansestimuli • Under stress og sanseoverstimulation: svært at udøve selvregulerinmg og mister let konntrollen • Svært at skifte opmærksomhed og overgå til nye aktiviteter; bliver let fraværende i egne tanker

  30. Naturhistorien for CHARGE • Mange patienter og mutationer beskrevet: man kan begynde at ane et billede for en del af symptomerne: ex.vækst/pubertet, hjertemisdannelser, adfærd

  31. Pubertet/vækst

  32. Pubertet/vækst: ”the R and the G” • Forskellige faser med forskelligt normal biologisk mønster i spædbarn-barndom og ved pubertet • Jeremy Kirk’s opsummering fra SENSE kan anbefales • Anbefaling: opfølgning af en pædiatrisk endokrinolog

  33. Pubertet

  34. Lugtesans/pubertet • Study on smell and puberty in CHARGE syndrome • Smell deficiency and delayed or absent puberty often occur in CHARGE syndrome, but few studies have looked if these features are associated in adolescents with CHARGE syndrome. Therefore, we studied smell and pubertal development in 35 individuals with CHARGE syndrome from the Netherlands. In this study, we included 19 boys and 16 girls aged 10 years or older who all had a mutation in the CHD7-gene. • We performed a smell test (the University of Pennsylvania Smell Identification Test, see the picture below) in all persons without mental retardation, bilateral choanal atresia and/or severe feeding difficulties (26/35). • Also, we re-analyzed MRI brain scans (whenever available) for abnormalities of the olfactory bulbs (the area in the brain involved in olfaction). Pubertal development was evaluated by a paediatricendocrinologist who did a physical exam and measured hormone levels in blood.

  35. Pubertet/lugtesans • How often does a smell deficit occur in CHARGE syndrome? • Smell testing showed absent sense of smell in 21/26 (81%) individuals and normal or slightly decreased sense of smell in 5/26 (19%) individuals. History taking was not reliable for determining sense of smell. • MRI brain scans were available in 10 persons, but could be analysedfor olfactory bulb abnormalities in only three persons. These three persons all had abnormal olfactory bulbs. • How often do individuals with CHARGE syndrome have delayed or absent puberty? • 23 Individuals were old enough to distinguish between delayed or normal puberty. In 17 persons puberty was delayed or absent (74%), whereas 6 persons had experienced normal puberty (26%).

  36. Pubertet/lugtesans • Was there a correlation between sense of smell and pubertal development? • From 15 individuals complete data on both smell and puberty were available: 11 persons had • both a smell deficit and delayed puberty and 4 persons had normal sense of smell in • combination with normal pubertal development. Seven boys were too young to know if they • would enter puberty at a normal age, but they all had cryptorchidism or a micropenis, which • is suggestive for delayed puberty. These seven boys had no sense of smell. Therefore, a • total of 22 persons showed concordance between smell and (suspected) pubertal • development. We conclude that smell and pubertal development are 100% correlated in this • study. • Can a smell test predict whether spontaneous puberty will occur? • Because of the correlation between sense of smell and pubertal development, a smell test • can probably predict whether spontaneous puberty will occur. When a patient with CHARGE • syndrome is unable to smell, he/she will probably need hormone replacement therapy to • enter puberty. We recommend timely start of hormone replacement therapy in children with • CHARGE syndrome who have no sense of smell to make sure they enter puberty • simultaneously with their peers. This will reduce social problems and risk of osteoporosis • (brittle bone disease).

  37. Fraværende lugtesans som prædiktor af udebleven spontan pubertet? • 35 personer m. CHD7 mutation • Komplette data på 15 pts:11 havde komplet anosmi og HH • 4 hypo/normo osmi + spontan pubertet • Konklusion:Opstart af hormonel induktion af pubertet på alders-adækvat tidspunkt Bergman JEH et al; J Pediatrics 2011;158:474-479

  38. Klinisk 0pfølgning-del1

  39. Klinisk 0pfølgning-del2-ENT-part 1

  40. Klinisk 0pfølgning-del3-ENT-part 2

  41. Klinisk 0pfølgning-del 4

  42. Klinisk 0pfølgning-del 5

  43. Klinisk 0pfølgning-del 6

  44. Klinisk 0pfølgning-del 7

  45. Klinisk 0pfølgning-del 8

  46. Differentialdiagnoser til CHARGE • Hvad så??

  47. CHARGE?? • KR 211298: • Bilat Choanal atresi, ve.sid iris colobom, VSD + DAP, corpus callosum agenesi,ADHD, Tourette lign verbale udsagn, agenesi af permente tænder, dysmorf, kranienervedysfunktion? (smil), ikke CT scannet for semicirkulære kanaler, ingen HN, ingen genital hypoplasi. • CHD7-sekv: N, MLPA:N , • Kromosomanalyse: normal, array CGH Normal

  48. KR 211298 CHARGE?- mutation i ukendt gen? Kromosomsyndrom?

  49. Nyttige informationskilder • http://www.servicestyrelsen.dk/dovblindfodt • Artikler, indtryk fra SENSe konferencen marts 2011 mm • Præsentationer fra CHARGE samlingen 11.3-13.3 2011 i UK: www.sense.org.uk • http://www.chargesyndrome.org.uk

More Related